Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2009: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2008: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2007: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
Research Abstract |
Dentatorubral-pallidoluysian atrophy (DRPLA ; MIM125370) is an autosomal dominant neurodegenerative disorder caused by unstable expansion of a CAG trinucleotide repeat in exon 5 which codes for a polyglutamine stretch. Nowadays, there is no treatment ways for DRPLA patient, because DRPLA protein fuction remains unclear. To develop for the therapy for DRPLA, we examined DRPLA protein biochemical function deeply.
|